Related Experiment Video
Updated: Mar 7, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein
Muhan Chen1, Dawid G Nowak1, Navneet Narula2,3
1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724.
Abstract:
Phosphatase and tensin homologue (PTEN) protein levels are critical for tumor suppression. However, the search for a recurrent cancer-associated gene alteration that causes PTEN degradation has remained futile. In this study, we show that Importin-11 (Ipo11) is a transport receptor for PTEN that is required to physically separate PTEN from elements of the PTEN degradation machinery. Mechanistically, we find that the E2 ubiquitin-conjugating enzyme and IPO11 cargo, UBE2E1, is a limiting factor for PTEN degradation. Using in vitro and in vivo gene-targeting methods, we show that Ipo11 loss results in degradation of Pten, lung adenocarcinoma, and neoplasia in mouse prostate with aberrantly high levels of Ube2e1 in the cytoplasm. These findings explain the correlation between loss of IPO11 and PTEN protein in human lung tumors. Furthermore, we find that IPO11 status predicts disease recurrence and progression to metastasis in patients choosing radical prostatectomy. Thus, our data introduce the IPO11 gene as a tumor-suppressor locus, which is of special importance in cancers that still retain at least one intact PTEN allele.
Insights
Importin-11 (Ipo11) transports PTEN, preventing its degradation. Loss of Ipo11 leads to PTEN loss, promoting lung adenocarcinoma and prostate cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- PTEN protein is crucial for tumor suppression.
- Mechanisms driving PTEN degradation in cancer are not fully understood.
Purpose of the Study:
- Investigate the role of Importin-11 (Ipo11) in PTEN regulation.
- Determine the mechanism by which Ipo11 affects PTEN stability and function.
- Evaluate IPO11 as a potential tumor suppressor and prognostic marker.
Main Methods:
- In vitro and in vivo gene targeting.
- Analysis of protein levels and cellular localization.
- Correlation studies in human lung and prostate cancer tissues.
Main Results:
- Ipo11 acts as a PTEN transport receptor, protecting it from degradation machinery.
- UBE2E1, an Ipo11 cargo, is a rate-limiting factor for PTEN degradation.
- Ipo11 loss causes PTEN degradation, leading to lung adenocarcinoma and prostate neoplasia in mice.
- Loss of IPO11 correlates with decreased PTEN protein in human lung tumors.
- IPO11 status predicts recurrence and metastasis in prostate cancer patients.
Conclusions:
- IPO11 is a tumor suppressor locus critical for maintaining PTEN protein levels.
- IPO11 function is essential in cancers with intact PTEN alleles.
- IPO11 is a potential prognostic biomarker for cancer recurrence and metastasis.
Related Concept Videos
Nuclear Localization Signals and Import
Regulation of Nuclear Protein Sorting
Abnormal Proliferation
Directionality of Nuclear Transport
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...

